Promoting the Ethical Care of Persons with Opioid Use Disorder: Considerations to maintain patient privacy and autonomy
Over nine million adults in the US meet clinical criteria for opioid use disorder (OUD) yet fewer than one in four will receive evidence-based treatment with medication for OUD. Treatment for OUD saves lives but may also introduce challenges in the workplace, within families, and with insurers leading many of those living with OUD to opt out of receiving treatment. To avoid some of these challenges, patients may opt to self-pay for treatment services to maintain their privacy. In this webinar, Tyler Varisco, lead author of NCPA's Pharmacy Access to Resources and Medication for Opioid Use Disorder Practice Guideline, will moderate a discussion between Elliot Pinsly, a licensed clinical social worker, policy expert, and CEO of the Behavioral Health Foundation, and Jon Larsen, an attorney and legal technology manager at Temple University's Beasley School of Law Center for Public Health Law Research. The panelists will discuss implications of HIPAA, 45 CFR Part 2, and the Americans with Disabilities Act for the care of patients with OUD. Participants will leave with an enhanced understanding of maintaining patient privacy when providing care for patients with OUD.
Over nine million adults in the US meet clinical criteria for opioid use disorder (OUD) yet fewer than one in four will receive evidence-based treatment with medication for OUD. Treatment for OUD saves lives but may also introduce challenges in the workplace, within families, and with insurers leading many of those living with OUD to opt out of receiving treatment. To avoid some of these challenges, patients may opt to self-pay for treatment services to maintain their privacy. In this webinar, Tyler Varisco, lead author of NCPA's Pharmacy Access to Resources and Medication for Opioid Use Disorder Practice Guideline, will moderate a discussion between Elliot Pinsly, a licensed clinical social worker, policy expert, and CEO of the Behavioral Health Foundation, and Jon Larsen, an attorney and legal technology manager at Temple University's Beasley School of Law Center for Public Health Law Research. The panelists will discuss implications of HIPAA, 45 CFR Part 2, and the Americans with Disabilities Act for the care of patients with OUD. Participants will leave with an enhanced understanding of maintaining patient privacy when providing care for patients with OUD.
Learning Objectives
1. Describe existing privacy protections for patients with OUD and identify changes to privacy law related to the Protecting Jessica Grubb's Legacy Act.
2. Explain why patients in treatment may be concerned about non-consensual disclosure of protected health information to payers or other covered entities.
3. Develop a plan to protect the privacy of patients with opioid use disorder to help them reach their treatment goals.
04. Speaker(s)
- Elliot Pinsly, President and CEO, Behavioral Health Foundation
- Tyler Varisco, PharmD, PhD, Assistant Professor, Department of Pharmaceutical Health Outcomes and Policy at the University of Houston College of Pharmacy
- Jonathan Larsen, Legal Technology Manager, Center for Public Health Law Research, Temple University
05. Speaker Disclosure Statement
There are no relevant financial relationships with ACPE defined commercial interests for anyone who was in control of the content of the activity.
07. Pharmacist ACPE UAN#
08. Pharmacy Technician ACPE UAN#
09. Contact Hours
ACPE Statement
NCPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program will provide 1.0 contact hours (0.1 CEUs) of continuing pharmacy education credit.
Activity Type
Instructions for Participation
To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:
1. Review the content of the activity.
2. Successfully complete the final assessment (70% or higher).
You will have two (2) opportunities to successfully complete the activity. Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the feedback survey.
Interest
- Law/Regulatory
- Opioids/Pain management
Software Requirements
Google Chrome (Latest Version) – Recommended Browser
Microsoft Edge (Latest Version)
Firefox (Latest Version)
Safari (Latest Version)
Adobe Acrobat Reader *REQUIRED TO VIEW PRINTABLE VERSION OF ANY PDF FILES*
Target Audience
Activities: | Type |
---|---|
Promoting the Ethical Care of Persons with Opioid Use Disorder: Considerations to maintain patient privacy and autonomy | Empty |
Promoting the Ethical Care of Persons with Opioid Use Disorder: Considerations to maintain patient privacy and autonomy - Pre-test | NCPA Pre-Test |
Promoting the Ethical Care of Persons with Opioid Use Disorder: Considerations to Maintain Patient Privacy and Autonomy - Pre-Test Likert | NCPA Pre-Test |
Promoting the Ethical Care of Persons with Opioid Use Disorder: Considerations to maintain patient privacy and autonomy - Video | NCPA Video |
Promoting the Ethical Care of Persons with Opioid Use Disorder: Considerations to maintain patient privacy and autonomy - Final Assessment | NCPA Post-Test |
Promoting the Ethical Care of Persons with Opioid Use Disorder: Considerations to Maintain Patient Privacy and Autonomy - Final Likert | NCPA Post-Test |

Estimated Learning Time:
The following credits are available upon completion of these activities.